Lyfnua (gefapixant) / Merck (MSD) |
| Not yet recruiting | 3 | 414 | Europe, RoW | MK-7264, Film-coated tablet | Merck Sharp & Dohme Corp., a subsidiary of Merck & Co.,Inc, Merck Sharp & Dohme Corp., a subsidiary of Merck & Co.,Inc | Chronic Cough, Chronic Cough, Diseases [C] - Respiratory Tract Diseases [C08] | | | | |
2019-002321-29: Efficacy of Gefapixant in Women with Chronic Cough and Stress Urinary Incontinence |
|
|
| Not yet recruiting | 3 | 380 | Europe, RoW | MK-7264, Film-coated tablet | Merck Sharp & Dohme Corp., a subsidiary of Merck & Co.,Inc, Merck Sharp & Dohme Corp., a subsidiary of Merck & Co.,Inc | Chronic Cough and Stress Urinary Incontinence, Chronic Cough and Stress Urinary Incontinence, Diseases [C] - Respiratory Tract Diseases [C08] | | | | |
2015-002034-47: A study to determine the effect of AF-219 on the urge to cough in patients with long-term cough |
|
|
| Not yet recruiting | 2 | 36 | Europe | AF-219, Tablet | Afferent Pharmaceuticals, Inc., Afferent Pharmaceuticals, Inc. | Chronic cough, Long-term cough, Diseases [C] - Respiratory Tract Diseases [C08] | | | | |
NCT05813223: Effect of Gefapixant on Cough-related Brain Activity in Patients With Chronic Cough |
|
|
| Recruiting | 1 | 31 | RoW | Gefapixant, Merck (MK)-7264 | Stuart Mazzone, Merck Sharp & Dohme LLC, Melbourne Health, Monash University | Chronic Cough | 10/25 | 06/26 | | |
| Recruiting | N/A | 63 | Japan | Gefapixant Citrate, LYFNUA Tablets | Nagoya City University, Merck Sharp & Dohme LLC | Chronic Cough | 03/26 | 06/26 | | |